← FDA Drug Approvals (Drugs@FDA)

TIMENTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAXOSMITHKLINE · Approved 1986-12-19

Drug application

FDA Application #

ANDA062691

Application type

Abbreviated New Drug Application (Generic)

Brand name

TIMENTIN

Generic name

Clavulanate Potassium

Active ingredients

CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

GLAXOSMITHKLINE

First approval

1986-12-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown